Semi-Annual Consolidated Balance Sheet

Kringle Pharma,Inc. - Filing #7264672

Concept As at
2025-03-31
As at
2024-09-30
Semi-annual consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,886,137,000 JPY
2,313,475,000 JPY
Other
14,184,000 JPY
23,993,000 JPY
Current assets
2,265,125,000 JPY
2,755,990,000 JPY
Non-current assets
Property, plant and equipment
JPY
JPY
Property, plant and equipment
Investments and other assets
24,982,000 JPY
1,122,000 JPY
Investments and other assets
Non-current assets
24,982,000 JPY
1,122,000 JPY
Assets
2,290,108,000 JPY
2,757,113,000 JPY
Liabilities
Current liabilities
Income taxes payable
745,000 JPY
1,490,000 JPY
Asset retirement obligations
3,900,000 JPY
JPY
Other
13,574,000 JPY
25,488,000 JPY
Current liabilities
155,826,000 JPY
128,172,000 JPY
Non-current liabilities
Asset retirement obligations
JPY
2,305,000 JPY
Non-current liabilities
525,571,000 JPY
520,748,000 JPY
Liabilities
681,397,000 JPY
648,921,000 JPY
Net assets
Share capital
12,122,000 JPY
11,300,000 JPY
Shareholders' equity
Capital surplus
2,841,101,000 JPY
2,835,204,000 JPY
Retained earnings
-1,268,943,000 JPY
-756,453,000 JPY
Treasury shares
-106,000 JPY
-106,000 JPY
Shareholders' equity
1,584,173,000 JPY
2,089,944,000 JPY
Share acquisition rights
24,536,000 JPY
18,247,000 JPY
Net assets
1,608,710,000 JPY
2,108,192,000 JPY
Liabilities and net assets
2,290,108,000 JPY
2,757,113,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.